Keratotic papules on a patient with chronic kidney disease

Authors

  • María Laura Sanz Churruca Visca Hospital, City of Buenos Aires, Argentina
  • María Pía Herlein Churruca Visca Hospital, City of Buenos Aires, Argentina
  • Silvana Alejandra León Churruca Visca Hospital, City of Buenos Aires, Argentina
  • Graciela Luján Carabajal Churruca Visca Hospital, City of Buenos Aires, Argentina

DOI:

https://doi.org/10.47196/da.v31i2.2881

Keywords:

keratotic papules, kidney failure, dermatology

Abstract

A 54-year-old male patient with a history of high blood pressure, type 2 diabetes mellitus, and chronic kidney disease, for which he was undergoing hemodialysis, presented to our department with pruritic dermatosis of 3 months' duration. Physical examination revealed numerous hyperpigmented papules and nodules with a keratotic center, measuring 0.3 to 0.7 mm in diameter, located on the back. Symptomatic treatment with antihistamines and emollients was prescribed, and a skin biopsy was performed for histopathological examination. This study revealed central epidermal depression with marked thinning and infiltration of nonspecific eosinophilic fibers. Basophilic debris and a mixed inflammatory infiltrate were observed in the immediately underlying dermis. Using the Masson trichrome staining technique, these fibers stained blue, corresponding to collagen fibers.

Author Biographies

  • María Laura Sanz, Churruca Visca Hospital, City of Buenos Aires, Argentina

    Dermatology Resident Physician

  • María Pía Herlein, Churruca Visca Hospital, City of Buenos Aires, Argentina

    Chief Resident of Dermatology

  • Silvana Alejandra León, Churruca Visca Hospital, City of Buenos Aires, Argentina

    Head of the Dermatology Service

  • Graciela Luján Carabajal, Churruca Visca Hospital, City of Buenos Aires, Argentina

    Staff Physician, Pathological Anatomy Service

References

I. Rodríguez-Patiño G, Mercadillo-Pérez P, Dermatosis perforantes. Características clínico-patológicas en México. Rev Med Hosp Gen Mex. 2009;72:20-25.

II. González-Lara L, Gómez-Bernal S, Vázquez-López F, Vivanco-Allende B. Dermatosis perforante adquirida: presentación de 8 casos. Actas Dermosifiliogr. 2014;105:e39-e43.

III. Rapini RP, Hebert AA, Drucker CR. Acquired perforating dermatosis. Evidence for combined transepidermal elimination of both collagen and elastic fibers. Arch Dermatol. 1989;125:1074-1078.

IV. Trucco L, Ramírez MI, Acciarri ML, Balboa ES, et ál. Dermatosis perforante adquirida. Rev Argent Dermatol. 2020;10:31-42.

V. Helberth JC, Salamanca AP, Peñaranda E. Dermatosis perforante adquirida: tratamiento con alopurinol. Rev Asoc Col Dermatol. 2009;17:134-137.

VI. Castellanos-Posse ML, Nocito MJ, Garuti RA, Carmona-Cuello LE, et ál. Dermatosis perforantes: presentación de 8 casos. Med Cutan Iber Lat Am. 2012;40:147-153.

VII. Gómez JF, Espinosa MS, Civale CM, Cóppola M, et ál. Colagenosis perforante reactiva. Dermatol Argent. 2019;25:78-80.

VIII. Kawakami T, Akiyama M, Ishida-Yamamoto A, et ál. Clinical practice guide for the treatment of perforating dermatosis. J Dermatol. 2020;47:1374-1382.

Downloads

Published

2025-08-01

Issue

Section

What is your Diagnosis?